Oesch-Régeni, B.; Germann, N.; Hafer, G.; Schmid, D.; Arn, N.
The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study. J. Clin. Med. 2025, 14, 3802.
https://doi.org/10.3390/jcm14113802
AMA Style
Oesch-Régeni B, Germann N, Hafer G, Schmid D, Arn N.
The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study. Journal of Clinical Medicine. 2025; 14(11):3802.
https://doi.org/10.3390/jcm14113802
Chicago/Turabian Style
Oesch-Régeni, Boglárka, Nicolas Germann, Georg Hafer, Dagmar Schmid, and Norbert Arn.
2025. "The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study" Journal of Clinical Medicine 14, no. 11: 3802.
https://doi.org/10.3390/jcm14113802
APA Style
Oesch-Régeni, B., Germann, N., Hafer, G., Schmid, D., & Arn, N.
(2025). The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study. Journal of Clinical Medicine, 14(11), 3802.
https://doi.org/10.3390/jcm14113802
